
Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib
Keywords: اینترفرون-γ; AFP; alpha fetoprotein; CI; confidence interval; DNA; deoxyribonucleic acid; EGF; epidermal growth factor; FGF; fibroblast growth factor; G-CSF; granulocyte colony-stimulating factor; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HR; hazard ratio